Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Biomaterials|September 1, 2019
Synthesis of a long acting nanoformulated emtricitabine ProTideDhruvkumar Soni, Aditya N Bade, Nagsen Gautam, et al.Nature Communications|February 7, 2018
Creation of a long-acting nanoformulated dolutegravirBrady Sillman, Aditya N Bade, Prasanta K Dash, et al.The Journal of Clinical Investigation|January 31, 2017
Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugsDivya Prakash Gnanadhas, Prasanta K Dash, Brady Sillman, et al.Nature Communications|June 9, 2021
Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravirNagsen Gautam, JoEllyn M McMillan, Devendra Kumar, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|September 7, 2019
Creation of a long-acting rilpivirine prodrug nanoformulationJames R Hilaire, Aditya N Bade, Brady Sillman, et al.Biomaterials|December 20, 2014
Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulationsPavan Puligujja, Shantanu S Balkundi, Lindsey M Kendrick, et al.Theranostics|January 2, 2018
Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell BiodistributionBhavesh D Kevadiya, Christopher Woldstad, Brendan M Ottemann, et al.Nature Communications|June 10, 2022
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulationSuyash Deodhar, Brady Sillman, Aditya N Bade, et al.Nature Materials|April 29, 2020
A year-long extended release nanoformulated cabotegravir prodrugTanmay A Kulkarni, Aditya N Bade, Brady Sillman, et al.Nature Communications|July 4, 2019
Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized MicePrasanta K Dash, Rafal Kaminski, Ramona Bella, et al.Pageof 4